About BRASS
The Brigham and Women’s Hospital Rheumatoid Arthritis Sequential Study (BRASS), under the direction of Dr. Nancy Shadick and Dr. Michael Weinblatt, has worked to determine how genes can be used to predict whether Rheumatoid Arthritis (RA) will be mild or severe and to better understand how individuals respond to different drug treatments.
BRASS has over 1,500 people diagnosed with RA who are patients at the Brigham and Women’s Hospital and who are followed in the clinic annually and sent questionnaires at six-month intervals over a 15-year time span. Additionally, BRASS provides investigators with access to subsets of data as well as methodological support.
